Aadi Bioscience, Inc. (AADI)

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	148.99	4.46	38.56	62.65	20.29	1.63	0.02
Short-Term Investments	0	0	0	0	0	0.05	0
Cash & Cash Equivalents	148.99	4.46	38.56	62.65	20.29	1.68	0.02
Cash Growth	3244.31%	-88.45%	-38.45%	208.87%	1106.97%	8970.40%	-
Receivables	0	14.15	0	0	0	0	0
Other Current Assets	2.28	0.08	1.01	1.33	0.61	0.54	0
Total Current Assets	151.27	18.69	39.57	63.98	20.9	2.23	0.02
Property, Plant & Equipment	0.61	0.14	0.33	0.1	0.11	0.15	0
Goodwill and Intangibles	3.81	0	0	0	0	0	0
Other Long-Term Assets	2.21	0	0.04	0.04	0.02	0.02	-
Total Long-Term Assets	6.64	0.14	0.37	0.14	0.13	0.17	0
Total Assets	157.91	18.83	39.94	64.12	21.03	2.4	0.02
Accounts Payable	12.2	16.71	3.23	5.46	3.59	2.47	0
Current Debt	0.13	9.15	0.1	0	0	12.39	0.16
Other Current Liabilities	2.95	4.2	0	0	0	0	0.04
Total Current Liabilities	15.27	30.06	3.33	5.46	3.59	14.86	0.21
Long-Term Debt	0.47	1.1	0.07	0	0	0	0
Other Long-Term Liabilities	5.76	0.1	0	-	-	73.76	-
Total Long-Term Liabilities	6.23	1.2	0.07	0	0	73.76	0
Total Liabilities	21.5	31.26	3.4	5.46	3.59	88.62	0.21
Total Debt	0.61	10.26	0.17	0	0	12.39	0.16
Debt Growth	-94.10%	5933.19%	-	-	-	7641.65%	-
Common Stock	279.09	20.16	178.77	177.63	126	0	0.05
Retained Earnings	-142.69	-32.6	-142.24	-118.96	-108.56	-86.22	-0.24
Shareholders' Equity	136.41	-12.43	36.54	58.67	17.44	-86.22	-0.19
Total Liabilities and Equity	157.91	18.83	39.94	64.12	21.03	2.4	0.02
Net Cash / Debt	148.38	-5.8	38.39	62.65	20.29	-10.71	-0.14
Net Cash / Debt Growth	-	-	-38.72%	208.87%	-	-	-
Net Cash Per Share	16.63	-2.28	14.19	27.70	14.04	-188.34	-0.42
Working Capital	136	-11.37	36.24	58.53	17.31	-12.63	-0.19
Book Value Per Share	15.29	-4.89	13.50	25.93	12.07	-1.00	-0.56

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).